Prostate cancer: important steps and considerations in the design of therapeutic vaccines


Autoria(s): McArdle, S. E. B.; Pockley, A. G.; Gibson, Glenn R.; Rees, R. C.
Data(s)

2014

Resumo

Vaccine-based immunotherapy can increase the overall survival of patients with advanced prostate cancer. However, the efficacy of vaccine-elicited anticancer immune responses is heavily influenced by the physical, nutritional, and psychological status of the patient. Given their importance, these parameters should be carefully considered for the design of future clinical trials testing this immunotherapeutic paradigm in prostate cancer patients.

Formato

text

Identificador

http://centaur.reading.ac.uk/40421/1/onci%252E28049.pdf

McArdle, S. E. B., Pockley, A. G., Gibson, G. R. <http://centaur.reading.ac.uk/view/creators/90000347.html> and Rees, R. C. (2014) Prostate cancer: important steps and considerations in the design of therapeutic vaccines. Oncoimmunology, 3 (3). e28049. ISSN 2162-402X doi: 10.4161/onci.28049 <http://dx.doi.org/10.4161/onci.28049>

Idioma(s)

en

Publicador

Taylor & Francis

Relação

http://centaur.reading.ac.uk/40421/

creatorInternal Gibson, Glenn R.

10.4161/onci.28049

Direitos

cc_by

Tipo

Article

PeerReviewed